| Financial Year |
March 31 2023 |
| Monetary Funds |
6,803,304,117.19 |
| Held-for-trading Financial Assets |
1,998,236,082.95 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,262,862,114.44 |
| Advances to Suppliers |
38,758,095.11 |
| Other Receivables |
488,332,709.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
4,514,036.03 |
| Inventories |
12,787,057,693.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
754,374,708.28 |
| Total Current Assets |
24,132,925,520.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
46,519,553.56 |
| Long-term Equity Investment |
2,078,108,520.11 |
| Investment Properties |
12,809,011,739.43 |
| Fixed Assetes |
9,192,453,306.09 |
| Under-construction Projects |
1,214,694,497.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,008,591,841.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,357,467.05 |
| Deferred Income Tax Assets |
789,797,190.68 |
| Other Non-Current Assets |
1,290,093,026.19 |
| Sub-Total of Non-Current Assets |
31,779,233,535.69 |
| Total Assets |
55,912,159,055.86 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,029,048.37 |
| Accounts Payable |
3,185,139,975.98 |
| Accounts Received In Advance |
42,550,562.38 |
| Employee Compensation Payable |
312,917,846.69 |
| Taxes Payable |
2,593,441,791.81 |
| Interest Payable |
30,158,665.71 |
| Dividend Payable |
27,335,435.00 |
| Other payables |
1,666,117,384.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
397,467,381.54 |
| Other Current Liabilities |
110,600,566.22 |
| Sub-Total of Current Liabilities |
10,587,196,840.70 |
| Long-term Loans |
18,759,709,877.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
176,451,141.13 |
| Special Payable |
-- |
| Estimatied Liabilities |
2,935,648.18 |
| Deferred Income Tax Liabilities |
1,236,086,305.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
21,201,570,442.74 |
| Total Liabilities |
31,788,767,283.44 |
| Paid-In Capital(Or Share Stock) |
11,425,309,602.00 |
| Capital Surplus |
26,991,768,111.08 |
| Surplus Reserve |
193,994,913.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-14,584,126,676.24 |
| Minority Stockholder's Interest |
1,441,259,421.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
22,682,132,351.00 |
| Owner's Equity（Stockholder's Equity） |
24,123,391,772.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
55,912,159,055.86 |
